Іздеу

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

Том 30, № 3 (2023)

Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination

Biryukova E., Shinkin M., Morozova I.

(Rus)

Том 30, № 3 (2023)

Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series

Smirnova E.

(Rus)

Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin

Biryukova E.

(Rus)

Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus

Demidov N.

(Rus)

The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus

Petrov V., Shatalova O., Klykova M., Stetsky N.

(Rus)

Screening, diagnosis and treatment of early carbohydrate metabolism disorders

Demidova I., Boeva V.

(Rus)

Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection

Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.

(Rus)

Vildagliptin – 15 years in active service with diabetologists

Pavlova M.

(Rus)

Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation

Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.

(Rus)

Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice

Elsukova O., Nikitina E., Chuprova A., Kaysina O.

(Rus)

Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus

Smirnova E.

(Rus)

The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow

Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.

(Rus)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution

Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.

(Rus)

How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary

Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.

(Rus)

Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

Markina J.

(Rus)

№ 20 (2014)

Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta

Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.

(Rus)

№ 11 (2012)

Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya

Mayorov A.

(Rus)

News of medicine

Kudinova S.

(Rus)

Том 28, № 4 (2021)

Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus

Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.

(Rus)

№ 16 (2012)

Monogennye formy sakharnogo diabeta

Zubkova N., Tikhonovich Y., Tyul'pakov A.

(Rus)

Том 28, № 4 (2021)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

№ 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

№ 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

№ 16 (2010)

SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Mkrtumyan A., Mkrtumyan A.

Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Novikova M., Demidov N.

(Rus)

Том 27, № 4 (2020)

Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?

Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.

(Rus)

№ 5 (2013)

SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA

Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.

(Rus)

№ 5 (2017)

CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Chemikova N.

(Rus)

Том 28, № 4 (2021)

Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus

Chernikova N., Knyshenko O., Ivanova L.

(Rus)

№ 5 (2015)

Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa

Demidova T.

(Rus)

Том 29, № 11/12 (2022)

Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review

Petunina N., Martirosyan N., Valeeva F.

(Rus)

Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics

Shorokhova P., Baranov V.

(Rus)

Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial

Shkurova N., Baranova N., Fedin A.

(Rus)

Том 26, № 4 (2019)

Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia

Pereverzev A., Ostroumova O., Tkacheva O.

(Rus)

№ 11 (2018)

Apelin: biological and pathophysiological effects

Dolgikh Y., Verbovoy A.

(Rus)

№ 5 (2017)

PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS

Ametov A.

(Rus)

№ 5 (2016)

EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Biryukova E.

(Rus)

№ 17 (2015)

Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike

Demidov N., Zakharova S., Zav'yalov A.

(Rus)

№ 10 (2015)

Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa

Gusenbekova D., Ametov A., Butaeva S.

(Rus)

№ 5 (2015)

Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa

Antsiferov M.

(Rus)

№ 5 (2014)

TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA

Kudinov V., Nichitenko M., Chesnikova A.

(Rus)

№ 5 (2013)

PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa

Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.

(Rus)

№ 11 (2012)

Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya

Shilov A., Abdullaeva A.

(Rus)

№ 3 (2012)

PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME

Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.

№ 16 (2011)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antciferov M.

№ 16 (2010)

INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH

Biryukova Y., Biryukova E.

№ 5 (2010)

Thiazide diuretics and arterial hypertension: the history is going on

E Chazova I., Fomin V., Chazova I., Fomin V.

№ 3 (2010)

Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?

Nedosugova L., Nedosugova L.

№ 3 (2009)

Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?

Mkrtumyan A., Mkrtumyan A.

Том 29, № 4 (2022)

Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin

Novikova M., Koteshkova O., Antsiferov M.

(Rus)

School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus

Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.

(Rus)

Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism

Verbovoy T., Lomonova T.

(Rus)

№ 11 (2018)

Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use

Biryukova E.

(Rus)

№ 17 (2015)

Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy

Verbovoy A., Tsanava I., Verbovaya N.

(Rus)

№ 5 (2014)

UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa

Antsiferov M., Koteshkova O.

(Rus)

№ 16 (2013)

Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom

Shavlovskaya O.

(Rus)

№ 16 (2013)

Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa

Chernikova N., Antsiferov M.

(Rus)

№ 5 (2013)

O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA

Biryukova E.

(Rus)

№ 3 (2012)

DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE

Peterkova V., Peterkova V.

№ 3 (2011)

HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS

Biryukova E., pl?midmagidsid Y.

№ 16 (2010)

CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS

Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.

№ 3 (2010)

Common bean (Phaseolus vulgaris L.)/

Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.

№ 3 (2010)

Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)

Antsiferov M., Antsiferov M.

№ 17 (2009)

LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa

Petunina N.

Том 29, № 11/12 (2022)

Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study

Antsiferov M., Demidov N., Safronova T., Mishra O.

(Rus)

Том 29, № 4 (2022)

The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women

Apetov S., Apetova V.

(Rus)

P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy

Chernikova N.

(Rus)

Том 28, № 3 (2021)

The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine

Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.

(Rus)

Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study

Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.

(Rus)

Том 27, № 4 (2020)

Is it possible to stop the diabetes epidemic?

Verbovoy A., Dolgikh Y., Verbovaya N.

(Rus)

Том 26, № 14 (2019)

Hypoglycemic drugs and drug-induced heart failure

Ostroumova O., Goloborodova I.

(Rus)

Том 26, № 4 (2019)

The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus

Antonova K., Tanashyan M., Maksimova M., Shakhparonova N., Romantsova T.

(Rus)

№ 16 (2017)

Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus

Tsvetkova I., Kaukova A., Belyakova N., Vasyutkova O., Konovalova O., Lareva A.

(Rus)

№ 5 (2017)

EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE

Demidov N., Antsiferov M., Dorofeeva L.

(Rus)

№ 5 (2016)

APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS

Antsiferov M.

(Rus)

№ 17 (2015)

Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa

Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.

(Rus)

№ 16 (2014)

Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa

Biryukova E.

(Rus)

№ 16 (2013)

Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa

Ametov A., Tertychnaya E.

(Rus)

№ 5 (2013)

SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV

Ametov A.

(Rus)

№ 20 (2012)

Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov

Ruyatkina L., Sorokin M.

(Rus)

№ 10 (2012)

Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii

Ametov A., Valitov B., Chernikova N., Antsiferov M.

(Rus)

№ 3 (2012)

GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Antsiferov M., Antsiferov M.

№ 3 (2011)

RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE

Glinkina I., Romantsova T., Glinkina I., Romantsova T.

№ 3 (2011)

TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS

Antsiferov M., Antsiferov M.

№ 17 (2009)

SOVREMENNYE PODKhODY K LEChENIYu SAKhARNOGO DIABETA TIPA 2 U MUZhChIN

Tishova Y., Kalinichenko S.

№ 3 (2009)

Metformin - pathogenetic drug of first-line in the treatment of type 2 diabetes

Zilov A., Zilov A.